Clinical Trial Update: Toripalimab in Combination With Axitinib in Patients With Localized Mucosal Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial investigating toripalimab in combination with axitinib for localized mucosal melanoma is ongoing, with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucosal Melanoma

Drugs mentioned

• Axitinib (Axitinib)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Mucosal Melanoma | Phase 2 | Status: UNKNOWN